DIANE GEARHART: Open Payments
NPI 1578010567 · BAKERSFIELD, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,338 in 175 payments from 25 companies in 2025. Trend: 2023 $3,985 · 2024 $4,235 · 2025 $3,338
Food & beverage: $3,224Education: $115
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $440 |
| UCB, Inc. | 17 | $420 |
| Teva Pharmaceuticals USA, Inc. | 26 | $288 |
| Biogen, Inc. | 11 | $260 |
| Merz Pharmaceuticals, LLC | 8 | $240 |
| Novartis Pharmaceuticals Corporation | 13 | $215 |
| Eisai Inc. | 12 | $184 |
| Amgen Inc. | 7 | $181 |
| SK Life Science, Inc. | 5 | $177 |
| Lundbeck LLC | 8 | $157 |
Products named: AUSTEDO XR, QULIPTA, Leqembi, KESIMPTA, Xeomin, Fintepla, VUMERITY, VYEPTI.
Industry payments across CA — which companies pay providers there.
